Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05530512 · ClinicalTrials.gov registry record · NA
Acupuncture Therapy and Hypertension
A NA study of Mild to Moderate Hypertension, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 2
- Study locations
NCT05530512: Recruiting NA study of Mild to Moderate Hypertension, sponsored by University of California, Irvine.
NCT05530512 is a NA study of Mild to Moderate Hypertension that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 72 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05530512, a NA study of Mild to Moderate Hypertension, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 2
- Study locations
Study Summary
Acupuncture therapy will be provided to reduce blood pressure in hypertensive patients. The mild to moderate hypertensive patients will be either on or off hypertensive medications. The course last for 8 weeks and the frequency is once a week.
Primary Outcome
Heart rate variability and its component will be evaluated with EKG.
Conditions Studied
Interventions
- OTHER electroacupuncture
Study Locations (2)
California
- Susan Samueli Integrative Health Institute - Irvine
- University of California, Irvine, Health Sciences Medical Center - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What NCT05530512 shows while recruiting
NCT05530512 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Mild to Moderate Hypertension appearing as the primary indexed condition, and to 1 intervention - of which electroacupuncture is the first listed.
NCT05530512 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05530512 about?
NCT05530512 is a clinical study titled "Acupuncture Therapy and Hypertension". Acupuncture therapy will be provided to reduce blood pressure in hypertensive patients. The mild to moderate hypertensive patients will be either on or off hypertensive medications. The course last for 8 weeks and the frequency is once a week.
What is the current status of trial NCT05530512?
This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2023-01-01. Estimated completion is 2027-03-31.
What conditions does trial NCT05530512 study?
This clinical trial studies the following conditions: Mild to Moderate Hypertension.
What interventions are being tested in trial NCT05530512?
The interventions under investigation include: electroacupuncture (OTHER).
Who is sponsoring clinical trial NCT05530512?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05530512 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05530512's enrollment target sits among peer trials
72 1090th of 2000 higher than 899 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI